Most Read Articles
Rachel Soon, 26 Jun 2018

MIMS Pharmacist presents an overview of phosphatidylcholine's physiological role, as well as contemporary research on its pharmacology and effects.

Tristan Manalac, 16 Dec 2017
Methylphenidates, but not amphetamines, when taken during the first trimester of pregnancy, slightly increase the risk of cardiac congenital malformations, a recent study has shown.
Saras Ramiya, 12 Aug 2016
Patient-centred care is the focus of the upcoming International World Pharmacists' Day Convention, which is coorganized by the Malaysian Community Pharmacy Guild (MCPG) and the Malaysian Pharmaceutical Society (MPS) in September.
Pearl Toh, Yesterday
The survival benefits conferred by blood pressure (BP) and lipid-lowering medications persist even after more than a decade following the end of the original trial, according to results from the ASCOT* Legacy study.

Multidisciplinary cardiac rehab programme improves CHD risk factors, patient's knowledge

Pearl Toh
30 Oct 2017

A multidisciplinary inpatient cardiac rehabilitation programme (CRP) helps reduce risk factors for coronary heart disease (CHD) and improves proper prescription of evidence-based medication as well as patient's knowledge about the disease, according to a study presented at SPCRS 2017.

Noting that CRP is constantly underutilized despite its well-established benefits, a multidisciplinary CRP involving a joint collaboration between the Department of Anaesthesia and Intensive Care, Department of Medicine and Geriatrics, and Department of Physiotherapy was implemented in Cardiac Care Unit (CCU) of Pok Oi Hospital in Hong Kong. 

The study included 310 patients (mean age 60.4 years,85.5 percent males, 75.5 percent had ACS*, 94.5 percent had PCI**) admitted to CCU with CHD after stabilization. Risk factors for CHD were identified by attending cardiologists followed by education programme about CHD and control of risk factors offered by nurses, during which the patient's knowledge on CHD was assessed before and after attending CRP using a standardize questionnaire. Selected patients who had undergone revascularization were referred to physiotherapist to facilitate early mobilization. Blood test was performed at admission and during follow-up at outpatient clinics.  

After a mean follow-up of 59 days, significant improvements from baseline were seen in various risk factors as assessed through blood sampling, including total cholesterol (C), LDL-C, HDL-C, and triglyceride (p<0.001 for all, except triglyceride, p=0.001). Fasting glucose (-12.5 percent; p<0.001) and HbA1c (-3.8 percent; p=0.018) were also significantly improved compared with baseline. [SPCRS 2017, abstract N-37]  

In addition, patient's knowledge improved by 14.3 percent after CRP, as indicated by increase in their questionnaire scores (12.14 vs 13.8; p<0.001). 

Compared with prescription at study recruitment, there was significant improvement in the percentage of prescription of evidence-based medications on discharge, including ACEIs*** (51.6 percent vs 71.3 percent), beta-blockers (51.0 percent vs 65.8 percent), and statins (97.7 percent vs 98.7 percent; all p<0.001).

“The multidisciplinary inpatient CRP was effective in reducing risk factors, prescription percentage of evidence-based medication and enhanced patient's knowledge,” concluded the authors.   

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 26 Jun 2018

MIMS Pharmacist presents an overview of phosphatidylcholine's physiological role, as well as contemporary research on its pharmacology and effects.

Tristan Manalac, 16 Dec 2017
Methylphenidates, but not amphetamines, when taken during the first trimester of pregnancy, slightly increase the risk of cardiac congenital malformations, a recent study has shown.
Saras Ramiya, 12 Aug 2016
Patient-centred care is the focus of the upcoming International World Pharmacists' Day Convention, which is coorganized by the Malaysian Community Pharmacy Guild (MCPG) and the Malaysian Pharmaceutical Society (MPS) in September.
Pearl Toh, Yesterday
The survival benefits conferred by blood pressure (BP) and lipid-lowering medications persist even after more than a decade following the end of the original trial, according to results from the ASCOT* Legacy study.